Normalization Of Anemia in Women
Symptoms of anemia in women are often dismissed as “normal,” especially when related to menstruation or postpartum fatigue, leading to widespread underdiagnosis and undertreatment.
Diagnostic Limitations
Traditional diagnostic thresholds were based largely on male populations, contributing to under-recognition of anemia in women.
Long-Term Risks of Unrecognized Anemia
Mild to moderate anemia can increase the risk of cardiovascular disease, cognitive decline, and poor mental health outcomes when left untreated in women.
Research Bias
Most clinical trials have centered around male physiology, leaving gaps in understanding how women uniquely experience and respond to iron deficiency and treatment.
Overlooked Causes in Women
Factors like menstruation, fibroids, pregnancy, and postpartum blood loss are often not sufficiently addressed in standard anemia workups or management plans.
Barriers to Care
Women may face cultural, social, and economic obstacles that limit access to iron-rich foods, diagnostic testing, and appropriate therapy.
Public Health Recommendations
Strategies to reduce the burden of IDA in women should include:
- Gender-sensitive diagnostic criteria
- Targeted screening in high-risk groups
- Access to affordable iron supplements
- Nutrition education and support programs
Reference
https://aornjournal.onlinelibrary.wiley.com/doi/10.1002/aorn.14397
